Back to Trades
Redmile Group, LLC
10% OwnerCIK 0001425738
Total Volume
$34.5M
11 filings
Purchases
$10.2M
2 buy txns
Sales
$19.6M
6 sell txns
Net Activity
-$9.4M
net sold
Profile
- Filings
- 11
- Buy transactions
- 2
- Sell transactions
- 6
- Companies
- 6
- Active
- 2025–2026
Redmile Group, LLC, 10% Owner, accounts for 11 disclosed filings worth $34.5M, spread across 6 companies, active 2025–2026. The record is net selling, with $10.2M in purchases against $19.6M in sales. The largest single open-market purchase on record is $10.2M in Attovia Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Aug 7 | ATTO Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | $10.2M |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Other | $0 |
| Jul 24 | ATRA Atara Biotherapeutics, Inc. | Redmile Group, LLC | Director | Exercise | $0 |
| Jun 15 | FATE FATE THERAPEUTICS INC | Redmile Group, LLC | Director, 10% Owner | Award | $181.1K |
| Apr 23 | FATE FATE THERAPEUTICS INC | Redmile Group, LLC | Director, 10% Owner | Other | $0 |
| Apr 22 | FATE FATE THERAPEUTICS INC | Redmile Group, LLC | Director, 10% Owner | Other | $7.4K |
| Apr 2 | ADCT ADC Therapeutics SA | Redmile Group, LLC | 10% Owner | Sell | $19.6M |
| Oct 28 | ADCT ADC Therapeutics SA | Redmile Group, LLC | 10% Owner | Other | $0 |
| Aug 26 | STTK Shattuck Labs, Inc. | Redmile Group, LLC | Director, 10% Owner | Award | $4.4M |
| Aug 15 | IGMS IGM Biosciences, Inc. | Redmile Group, LLC | Director, 10% Owner | Disposed | $6.7K |
| Jul 16 | STTK Shattuck Labs, Inc. | Redmile Group, LLC | Director, 10% Owner | Award | $27.2K |
11 filings